Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
about
Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010).Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.Dopamine modulates reward system activity during subconscious processing of sexual stimuli.Dopamine Regulates Approach-Avoidance in Human Sensation-Seeking.The effect of a dopamine antagonist on conditioning of sexual arousal in womenThe effects of fall-risk-increasing drugs on postural control: a literature review.Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.A systematic review on the impact of psychotropic drugs on electroencephalogram waveforms in psychiatry.Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward.Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.Vanishing clinical psychopharmacology.Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study.Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681.Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state.
P2860
Q34171734-5D0AFE8D-33AD-42CA-878E-02C7D3F3F44AQ34275762-2188B947-B601-409A-9766-1F62B7410F07Q34588695-6E8460F7-C428-42A0-9171-D801D3957F3DQ34996934-32FA26C1-F1AB-4CF8-8979-C021D01F92F0Q35982273-9849A550-D7AC-47EC-A976-B0F7E0BB218AQ36287869-E718535C-C3C5-4910-B0F6-BF170AC385DFQ36712693-30EB1466-360E-4369-A0E0-AF036A49FC7AQ38134320-8BD4E5B6-CF62-4A86-9F94-7E5012800E05Q38136311-317509BC-E8D7-49B6-B66F-6B8DD55726BBQ38217456-853B10C3-1FE2-4A1F-B4E1-5E1203D1CD27Q38911100-4F04CAE4-ABE4-47FF-982D-F9134E8D7196Q39062177-A6E050F0-369A-4430-B836-CADA17F9AD7AQ39784796-18BF031A-59E4-416B-A58A-B11AA7D23CE8Q40086970-EAB3DE4D-817A-4D73-A192-9DB05E5B9538Q42836394-D21F08DF-C326-44BE-95A9-BF18DB823B67Q44254954-DD43B3A3-A3F1-4958-AAED-F68009756B7AQ47746221-8FB31EFD-A34B-4DFD-841A-D4EE9434FF29Q47845091-457F6076-7A3B-43D3-B033-7763A57C0DF1Q48918400-1EEBE02E-CD49-403A-8C1D-EBE98DDBD9FAQ49217905-FB83320D-A53C-4286-82D3-C378109DA7EDQ50666702-9E855B16-BD1A-4021-93B2-D400D96B5620
P2860
Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Psychomotor and cognitive effe ...... d with placebo or haloperidol.
@en
Psychomotor and cognitive effects of a single oral dose of talnetant
@nl
type
label
Psychomotor and cognitive effe ...... d with placebo or haloperidol.
@en
Psychomotor and cognitive effects of a single oral dose of talnetant
@nl
prefLabel
Psychomotor and cognitive effe ...... d with placebo or haloperidol.
@en
Psychomotor and cognitive effects of a single oral dose of talnetant
@nl
P2093
P2860
P356
P1476
Psychomotor and cognitive effe ...... ed with placebo or haloperidol
@en
P2093
J A J Schmitt
J M A van Gerven
K L Franson
M Liem-Moolenaar
S J de Visser
P2860
P356
10.1177/0269881108094524
P407
P577
2008-08-28T00:00:00Z